Press release
NUTEX HEALTH REPORTS JUNE 30, 2025 SECOND QUARTER AND YEAR-TO-DATE FINANCIAL RESULTS
Total revenue of $455.8 million for the first half of 2025 versus $143.5 million for the first half of 2024, an increase of 217.5% Net income attributable to
About this update from Nutex Health Inc.
[{"type":"text","content":"\n \n \n Total revenue of $455.8 million for the first half of 2025\n versus $143.5 million for the first half of 2024, an increase of 217.5%\n \n \n Net income attributable to Nutex Health Inc. of $3.5 million for the first half of 2025 versus net loss of $0.7 million for the first half of 2024, an increase of $4.2 million\n \n \n \n \n Diluted income per share of $0.55 for the first half of 2025 versus a loss per share of $0.15 for the first half of 2024\n \n \n \n \n EBITDA of $51.1 million for the first half of 2025 versus $15.6 million for the first half of 2024, an increase of 227.4%\n \n \n \n \n Adjusted EBITDA of $144.4 million for the first half of 2025 versus $6.4 million for the first half of 2024, an increase\n \n \n of 2144.2%\n \n \n \n \n Net cash from operating activities of $78.2 million for the first half of 2025\n \n \n \n \n On August 14, 2025\n \n \n ,\n the Board of Directors authorized a stock repurchase program of up to $25.0 million of the Company's common stock\n \n \n HOUSTON, Nov. 18, 2025 /PRNewswire/ -- Nutex Health Inc. (\"Nutex Health\" or the \"Company\") (NASDAQ: NUTX), today announced financial results for the three and six months ended June 30, 2025. Nutex Health is a physician-led, integrated healthcare delivery system comprised of 24 state-of-the-art micro hospitals and hospital outpatient departments (HOPDs) in 11 states and primary care-centric, risk-bearing physician networks.\n \n Financial highlights for the three months ended \n June 30, 2025:\n \n \n Total revenue increased $167.9 million to $244.0 million for the three months ended June 30, 2025 as compared to total revenue of $76.1 million for the same period in 2024, an increase of 220.7%. Revenue from mature hospitals, which are hospitals opened prior to December 31, 2021, increased by 203.2% in 2025 compared to 2024.\n Total stock-based compensation expense for the three months ended June 30, 2025 was $78.7 million, an increase of approximately $78.8 million compared to the same period in 2024. Approximately 99% of total stock-based compensation expense of $78.7 million is due to the one-time obligations for under-construction and ramping hospitals.\n Operating income for the three months ended June 30, 2025 was $33.7 million compared to $5.3 million for the same period in 2024, representing a $28.4 million improvement year over...